Search research articles
Contact Us
Filters
Showing results (51-60 of 88) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
January 1, 1988
Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor
D W Robertson, N D Jones, J K Swartzendruber, et al.
Life Sciences
|
January 1, 1988
LY227942, an inhibitor of serotonin and norepinephrine uptake: biochemical pharmacology of a potential antidepressant drug
D T Wong, D W Robertson, F P Bymaster, et al.
Epilepsia
|
January 1, 1988
Pharmacological effects of enantiomers of 4-amino-N-(alpha-methylbenzyl)benzamide, a chemically novel anticonvulsant
J D Leander, D W Robertson, C R Clark, et al.
Breast Cancer Research and Treatment
|
January 1, 1986
Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells
L L Wei, B S Katzenellenbogen, D W Robertson, et al.
Critical Reviews in Biomedical Engineering
|
January 1, 1992
High-performance computing, high-speed networks, and configurable computing environments: progress toward fully distributed computing
W E Johnston, V L Jacobson, S C Loken, et al.
Journal of Neurochemistry
|
February 1, 1996
Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus
E A Engleman, D W Robertson, D C Thompson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1986
Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100
J S Hayes, V L Wyss, H C Wilson, et al.
Journal of Medicinal Chemistry
|
December 1, 1990
Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors
D W Robertson, W Bloomquist, M L Cohen, et al.
Journal of Medicinal Chemistry
|
January 24, 1992
Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships
D W Robertson, W B Lacefield, W Bloomquist, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Preparation and anticonvulsant activity of a series of functionalized alpha-aromatic and alpha-heteroaromatic amino acids
H Kohn, K N Sawhney, P LeGall, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 88) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
January 1, 1988
Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor
D W Robertson, N D Jones, J K Swartzendruber, et al.
Life Sciences
|
January 1, 1988
LY227942, an inhibitor of serotonin and norepinephrine uptake: biochemical pharmacology of a potential antidepressant drug
D T Wong, D W Robertson, F P Bymaster, et al.
Epilepsia
|
January 1, 1988
Pharmacological effects of enantiomers of 4-amino-N-(alpha-methylbenzyl)benzamide, a chemically novel anticonvulsant
J D Leander, D W Robertson, C R Clark, et al.
Breast Cancer Research and Treatment
|
January 1, 1986
Nitrosourea and nitrosocarbamate derivatives of the antiestrogen tamoxifen as potential estrogen receptor-mediated cytotoxic agents in human breast cancer cells
L L Wei, B S Katzenellenbogen, D W Robertson, et al.
Critical Reviews in Biomedical Engineering
|
January 1, 1992
High-performance computing, high-speed networks, and configurable computing environments: progress toward fully distributed computing
W E Johnston, V L Jacobson, S C Loken, et al.
Journal of Neurochemistry
|
February 1, 1996
Antagonism of serotonin 5-HT1A receptors potentiates the increases in extracellular monoamines induced by duloxetine in rat hypothalamus
E A Engleman, D W Robertson, D C Thompson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1986
Molecular basis for the in vitro and in vivo cardiotonic activities of AR-L100
J S Hayes, V L Wyss, H C Wilson, et al.
Journal of Medicinal Chemistry
|
December 1, 1990
Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors
D W Robertson, W Bloomquist, M L Cohen, et al.
Journal of Medicinal Chemistry
|
January 24, 1992
Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships
D W Robertson, W B Lacefield, W Bloomquist, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Preparation and anticonvulsant activity of a series of functionalized alpha-aromatic and alpha-heteroaromatic amino acids
H Kohn, K N Sawhney, P LeGall, et al.
Page
of 9